Exclusive

Publication

Byline

US Patent Issued on April 14 for "Modified S2 subunit of the coronavirus spike protein" (German Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,751, issued on April 14. "Modified S2 subunit of the coronavirus spike protein" was invented by Annika Kraemer-Kuehl (Seesen, Germany) and... Read More


US Patent Issued to The University of North Carolina at Chapel Hill on April 14 for "Methods and compositions for recombinant dengue viruses or vaccine and diagnostic development" (North Carolina Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,752, issued on April 14, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.). "Methods and compositions fo... Read More


US Patent Issued to Spiber on April 14 for "Protein fiber production method" (Japanese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,754, issued on April 14, was assigned to Spiber Inc. (Yamagata, Japan). "Protein fiber production method" was invented by Yunosuke Abe (Ts... Read More


US Patent Issued to TREFOIL THERAPEUTICS on April 14 for "Recombinant modified fibroblast growth factors and therapeutic uses thereof" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,756, issued on April 14, was assigned to TREFOIL THERAPEUTICS INC. (San Diego). "Recombinant modified fibroblast growth factors and therap... Read More


US Patent Issued to Bioniz Therapeutics on April 14 for "Peptides inhibiting gamma-c-cytokine activity and methods of use" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,757, issued on April 14, was assigned to Bioniz Therapeutics Inc. (La Jolla, Calif.). "Peptides inhibiting gamma-c-cytokine activity and m... Read More


US Patent Issued to Amgen on April 14 for "Interleukin-2 muteins for the expansion of T-regulatory cells" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,758, issued on April 14, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Interleukin-2 muteins for the expansion of T-regulatory cell... Read More


US Patent Issued to ENZENE BIOSCIENCES on April 14 for "Process of preparation of glucagon-like peptide-1 (GLP-1) receptor agonists and their analogs" (Indian Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,759, issued on April 14, was assigned to ENZENE BIOSCIENCES Ltd. (Pune Maharashtra, India). "Process of preparation of glucagon-like pepti... Read More


US Patent Issued to The General Hospital on April 14 for "Chimeric antigen receptors targeting CD79B and CD19" (Massachusetts Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,760, issued on April 14, was assigned to The General Hospital Corp. (Boston). "Chimeric antigen receptors targeting CD79B and CD19" was in... Read More


US Patent Issued to Sichuan Clover Biopharmaceuticals on April 14 for "Methods and compositions for purification of trimeric fusion proteins" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,761, issued on April 14, was assigned to Sichuan Clover Biopharmaceuticals Inc. (Chengdu, China). "Methods and compositions for purificati... Read More


US Patent Issued to ASKGENE PHARMA on April 14 for "Masked cytokines and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,762, issued on April 14, was assigned to ASKGENE PHARMA INC. (Camarillo, Calif.). "Masked cytokines and methods of use thereof" was invent... Read More